SEC Form 4 · accession 0001209191-15-062592
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen T Isaacs
Officer — President and CEO · Director
Period of report
Jul 24, 2015
Accepted (ET)
Jul 27, 2015 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 24, 2015 | X | 11,550 | $0.0001 | A | 154,321 | D | |
| Common Stock | Jul 24, 2015 | X | 366 | $1.66 | A | 154,687 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrant (right to buy) | $0.0001 | Jul 24, 2015 | X | 11,550 | D | Apr 15, 2011 | Apr 15, 2021 | Common Stock | 11,550 | 0 | D |
| Common Stock Warrant (right to buy) | $1.66 | Jul 24, 2015 | X | 366 | D | Apr 15, 2011 | Apr 15, 2016 | Common Stock | 366 | 0 | D |